Nurses Must Consider the Impact of Anticholinergic Medications in Schizophrenia Spectrum Disorders

References

• Ballesteros, A., Sánchez-Torres, A. M., López-Ilundain, J. M., Cabrera, B., Lobo, A., González-Pinto, A. M., Díaz-Caneja, C., Corripio, I., Vieta, E., de la Serna, E., Bobes, J., Usall, J., Contreras, F., Lorente-Omeñaca, R., Mezquida, G., Bernardo, M., & Cuesta, M. J. (2018). Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?Psychological Medicine, 48(13), 2247–2256. https://doi.org/10.1017/S0033291717003774
   PubMed Web of Science ®Google Scholar
• Bell, B., & Avery, A. (2021). Identifying anticholinergic burden in clinical practice. Prescriber, 32(3), 20–23. https://doi.org/10.1002/psb.1901
   Google Scholar
• Brébion, G., Bressan, R. A., Amador, X., Malaspina, D., & Gorman, J. M. (2004). Medications and verbal memory impairment in schizophrenia: The role of anticholinergic drugs. Psychological Medicine, 34(2), 369–374. https://doi.org/10.1017/s0033291703008900
   PubMed Web of Science ®Google Scholar
• Carnahan, R. M., Brown, G. D., Letuchy, E. M., Rubenstein, L. M., Gryzlak, B. M., Smith, M., Reist, J. C., Kelly, M. W., Schultz, S. K., Weckmann, M. T., & Chrischilles, E. A. (2017). Impact of programs to reduce antipsychotic and anticholinergic use in nursing homes. Alzheimer’s & Dementia (New York, N. Y.), 3(4), 553–561. https://doi.org/10.1016/j.trci.2017.02.003
   PubMedGoogle Scholar
• Chew, M. L., Mulsant, B. H., Pollock, B. G., Lehman, M. E., Greenspan, A., Kirshner, M. A., Bies, R. R., Kapur, S., & Gharabawi, G. (2006). A model of anticholinergic activity of atypical antipsychotic medications. Schizophrenia Research, 88(1-3), 63–72. https://doi.org/10.1016/j.schres.2006.07.011
   PubMed Web of Science ®Google Scholar
• Chew, M. L., Mulsant, B. H., Pollock, B. G., Lehman, M. E., Greenspan, A., Mahmoud, R. A., Kirshner, M. A., Sorisio, D. A., Bies, R. R., & Gharabawi, G. (2008). Anticholinergic activity of 107 medications commonly used by older adults. Journal of the American Geriatrics Society, 56(7), 1333–1341. https://doi.org/10.1111/j.1532-5415.2008.01737.x
   PubMed Web of Science ®Google Scholar
• Coupland, C., Hill, T., Dening, T., Morriss, R., Moore, M., & Hippisley-Cox, J. (2019). Anticholinergic drug exposure and the risk of dementia: A nested case-control study. Journal of the American Medical Association Internal Medicine, 179(8), 1084–1093. https://doi.org/10.1001/jamainternmed.2019.0677
   Google Scholar
• Cuny, P., Houot, M., Ginisty, S., Horowicz, S., Plassart, F., Mentec, H., & Eftekhari, P. (2017). Colite ischémique sous quétiapine associée à d’autres molécules anticholinergiques: À propos d’un cas [Quetiapine and anticholinergic drugs induced ischaemic colitis: A case study]. L’Encéphale, 43(1), 81–84. https://doi.org/10.1016/j.encep.2015.12.027
   PubMedGoogle Scholar
• Desmarais, J. E., Beauclair, L., & Margolese, H. C. (2012). Anticholinergics in the era of atypical antipsychotics: Short-term or long-term treatment. Journal of Psychopharmacology (Oxford, England), 26(9), 1167–1174. https://doi.org/10.1177/0269881112447988
   PubMed Web of Science ®Google Scholar
• Gerretsen, P., & Pollock, B. G. (2011). Drugs with anticholinergic properties: A current perspective on use and safety. Expert Opinion on Drug Safety, 10(5), 751–765. https://doi.org/10.1517/14740338.2011.579899
   PubMed Web of Science ®Google Scholar
• Graves-Morris, K., Stewart, C., Soiza, R. L., Taylor-Rowan, M., Quinn, T. J., Loke, Y. K., & Myint, P. K. (2020). The prognostic value of anticholinergic burden measures in relation to mortality in older individuals: A systematic review and meta-analysis. Frontiers in Pharmacology, 11, 570. https://doi.org/10.3389/fphar.2020.00570
   PubMed Web of Science ®Google Scholar
• Joshi, Y. B., Thomas, M. L., Braff, D. L., Green, M. F., Gur, R. C., Gur, R. E., Nuechterlein, K. H., Stone, W. S., Greenwood, T. A., Lazzeroni, L. C., MacDonald, L. R., Molina, J. L., Nungaray, J. A., Radant, A. D., Silverman, J. M., Sprock, J., Sugar, C. A., Tsuang, D. W., Tsuang, M. T., … Light, G. A. (2021). Anticholinergic medication burden-associated cognitive impairment in schizophrenia. American Journal of Psychiatry, Advance online publication. https://doi.org/10.1176/appi.ajp.2020.20081212
   Google Scholar
• Joshi, Y. B., Thomas, M. L., Hochberger, W. C., Bismark, A. W., Treichler, E., Molina, J., Nungaray, J., Cardoso, L., Sprock, J., Swerdlow, N. R., & Light, G. A. (2019). Verbal learning deficits associated with increased anticholinergic burden are attenuated with targeted cognitive training in treatment refractory schizophrenia patients. Schizophrenia Research, 208, 384–389. https://doi.org/10.1016/j.schres.2019.01.016
   PubMed Web of Science ®Google Scholar
• Kim, S. J., Jung, D., Shim, J. C., Moon, J. J., Jeon, D. W., Kim, Y. N., Seo, Y. S., Jung, S. S., Seo, B. J., & Kim, J. E. (2019). The effect of anticholinergic burden on cognitive and daily living functions in patients with schizophrenia. Asian Journal of Psychiatry, 46, 111–117. https://doi.org/10.1016/j.ajp.2019.10.013
   PubMed Web of Science ®Google Scholar
• Lee, J. H., Lim, J., Han, S. J., do Moon, S., Moon, H., Lee, S. Y., Kim, H., & Jung, H. W. (2021). Clinical outcomes associated with anticholinergic burden in older hospitalized patients with advanced cancer: A single-center database study. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer, 29(8), 4607–4614. https://doi.org/10.1007/s00520-021-06008-z
   PubMed Web of Science ®Google Scholar
• Lisibach, A., Benelli, V., Ceppi, M. G., Waldner-Knogler, K., Csajka, C., & Lutters, M. (2021). Quality of anticholinergic burden scales and their impact on clinical outcomes: A systematic review. European Journal of Clinical Pharmacology, 77(2), 147–162. https://doi.org/10.1007/s00228-020-02994-x
   PubMed Web of Science ®Google Scholar
• Lockery, J. E., Broder, J. C., Ryan, J., Stewart, A. C., Woods, R. L., Chong, T. T.-J., Cloud, G. C., Murray, A., Rigby, J. D., Shah, R., Storey, E., Ward, S. A., Wolfe, R., Reid, C. M., Collyer, T. A., & Ernst, M. E. (2021). A cohort study of anticholinergic medication burden and incident dementia and stroke in older adults. Journal of General Internal Medicine, 36(6), 1629–1637. https://doi.org/10.1007/s11606-020-06550-2
   PubMed Web of Science ®Google Scholar
• Lupu, A. M., Clinebell, K., Gannon, J. M., Ellison, J. C., & Chengappa, K. (2017). Reducing anticholinergic medication burden in patients with psychotic or bipolar disorders. The Journal of Clinical Psychiatry, 78(9), e1270–e1275. https://doi.org/10.4088/JCP.16m11269
   PubMed Web of Science ®Google Scholar
• Margolis, S. A., Kelly, D. A., Daiello, L. A., Davis, J., Tremont, G., Pillemer, S., Denby, C., & Ott, B. R. (2021). Anticholinergic/sedative drug burden and subjective cognitive decline in older adults at risk of Alzheimer’s Disease. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 76(6), 1037–1043. https://doi.org/10.1093/gerona/glaa222
   PubMed Web of Science ®Google Scholar
• Montastruc, F., Benevent, J., Touafchia, A., Chebane, L., Araujo, M., Guitton-Bondon, E., Durrieu, G., Arbus, C., Schmitt, L., Begaud, B., & Montastruc, J. L. (2018). Atropinic (anticholinergic) burden in antipsychotic-treated patients. Fundamental & Clinical Pharmacology, 32(1), 114–119. https://doi-org.utk.idm.oclc.org/10.1111/fcp.12321
   PubMed Web of Science ®Google Scholar
• Ogino, S., Miyamoto, S., Miyake, N., & Yamaguchi, N. (2014). Benefits and limits of anticholinergic use in schizophrenia: Focusing on its effect on cognitive function. Psychiatry and Clinical Neurosciences, 68(1), 37–49. https://doi.org/10.1111/pcn.12088
   PubMed Web of Science ®Google Scholar
• O’Reilly, K., O’Connell, P., Donohoe, G., Coyle, C., O’Sullivan, D., Azvee, Z., Maddock, K., Sharma, K., Sadi, H., McMahon, M., & Kennedy, H. (2016). Anticholinergic burden in schizophrenia and ability to benefit from psychosocial treatment programmes: A 3-year prospective cohort study. Psychological Medicine, 46(15), 3199–3211. https://doi.org/10.1017/S0033291716002154
   PubMed Web of Science ®Google Scholar
• Ozbilen, M., Adams, C. E., & Marley, J. (2012). Anticholinergic effects of oral antipsychotic drugs of typicals versus atypicals over medium- and long-term: Systematic review and meta-analysis. Current Medicinal Chemistry, 19(30), 5214–5218. https://doi.org/10.2174/092986712803530476
   PubMed Web of Science ®Google Scholar
• Rehse, M., Bartolovic, M., Baum, K., Richter, D., Weisbrod, M., & Roesch-Ely, D. (2016). Influence of antipsychotic and anticholinergic loads on cognitive functions in patients with schizophrenia. Schizophrenia Research and Treatment, 2016(4), 1–10. https://doi.org/10.1155/2016/8213165
   Google Scholar
• Reinold, J., Palese, F., Romanese, F., Logroscino, G., Riedel, O., & Pisa, F. E. (2019). Anticholinergic burden before and after hospitalization in older adults with dementia: Increase due to antipsychotic medications. International Journal of Geriatric Psychiatry, 34(6), 868–880. https://doi.org/10.1002/gps.5084
   PubMed Web of Science ®Google Scholar
• Stewart, C., Yrjana, K., Kishor, M., Soiza, R. L., Taylor-Rowan, M., Quinn, T. J., Loke, Y. K., & Myint, P. K. (2021). Anticholinergic burden measures predict older People’s physical function and quality of life: A systematic review. Journal of the American Medical Directors Association, 22(1), 56–64. https://doi.org/10.1016/j.jamda.2020.05.065
   PubMed Web of Science ®Google Scholar
• Tsoutsoulas, C., Mulsant, B. H., Kumar, S., Ghazala, Z., Voineskos, A. N., Menon, M., Pollock, B. G., & Rajji, T K. (2017). Anticholinergic burden and cognition in older patients with schizophrenia. The Journal of Clinical Psychiatry, 78(9), e1284–e1290. https://doi.org/10.4088/JCP.17m11523
   PubMed Web of Science ®Google Scholar
• Xiang, Y.-T., Dickerson, F., Kreyenbuhl, J., Ungvari, G. S., Wang, C.-Y., Si, T.-M., Lee, E. H. M., Chiu, H. F. K., Lai, K. Y. C., He, Y.-L., Yang, S.-Y., Chong, M.-Y., Tan, C.-H., Kua, E.-H., Fujii, S., Sim, K., Yong, M. K. H., Trivedi, J. K., Chung, E.-K., … Shinfuku, N. (2013). Common use of anticholinergic medications in older patients with schizophrenia: Findings of the research on Asian psychotropic prescription pattern (REAP) study, 2001-2009. International Journal of Geriatric Psychiatry, 28(3), 305–311. https://doi.org/10.1002/gps.3827
   PubMed Web of Science ®Google Scholar